A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis.

NCT00210886 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1109

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Infections
Pyelonephritis

Interventions

DRUG: levofloxacin

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

[object Object]